IL17A and myeloid sarcoma: Previous reports have already demonstrated that in patients with MS, higher levels of CD3+CD20+ cells are associated with an up-regulation of production of proinflammatory cytokines, such as IFN-γ, GM-CSF, IL-17, and TNFα [30].